Literature DB >> 18667590

Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model.

Shannon R Morey Kinney1, Dominic J Smiraglia, Smitha R James, Michael T Moser, Barbara A Foster, Adam R Karpf.   

Abstract

We analyzed DNA methyltransferase (Dnmt) protein expression and DNA methylation patterns during four progressive stages of prostate cancer in the transgenic adenocarcinoma of mouse prostate (TRAMP) model, including prostatic intraepithelial neoplasia, well-differentiated tumors, early poorly differentiated tumors, and late poorly differentiated tumors. Dnmt1, Dnmt3a, and Dnmt3b protein expression were increased in all stages; however, after normalization to cyclin A to account for cell cycle regulation, Dnmt proteins remained overexpressed in prostatic intraepithelial neoplasia and well-differentiated tumors, but not in poorly differentiated tumors. Restriction landmark genomic scanning analysis of locus-specific methylation revealed a high incidence of hypermethylation only in poorly differentiated (early and late) tumors. Several genes identified by restriction landmark genomic scanning showed hypermethylation of downstream regions correlating with mRNA overexpression, including p16INK4a, p19ARF, and Cacna1a. Parallel gene expression and DNA methylation analyses suggests that gene overexpression precedes downstream hypermethylation during prostate tumor progression. In contrast to gene hypermethylation, genomic DNA hypomethylation, including hypomethylation of repetitive elements and loss of genomic 5-methyldeoxycytidine, occurred in both early and late stages of prostate cancer. DNA hypermethylation and DNA hypomethylation did not correlate in TRAMP, and Dnmt protein expression did not correlate with either variable, with the exception of a borderline significant association between Dnmt1 expression and DNA hypermethylation. In summary, our data reveal the relative timing of and relationship between key alterations of the DNA methylation pathway occurring during prostate tumor progression in an in vivo model system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18667590      PMCID: PMC2835734          DOI: 10.1158/1541-7786.MCR-08-0040

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  35 in total

1.  Chromosomal instability and tumors promoted by DNA hypomethylation.

Authors:  Amir Eden; François Gaudet; Alpana Waghmare; Rudolf Jaenisch
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

2.  Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma.

Authors:  Wolfgang A Schulz; Jussi P Elo; Andrea R Florl; Sari Pennanen; Simon Santourlidis; Rainer Engers; Martin Buchardt; Hans-Helge Seifert; Tapio Visakorpi
Journal:  Genes Chromosomes Cancer       Date:  2002-09       Impact factor: 5.006

3.  DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.

Authors:  Daniel Vallböhmer; Jan Brabender; Dongyun Yang; Paul M Schneider; Ralf Metzger; Kathleen D Danenberg; Arnulf H Hölscher; Peter V Danenberg
Journal:  Clin Lung Cancer       Date:  2006-07       Impact factor: 4.785

4.  DNA methylation pathway alterations in an autochthonous murine model of prostate cancer.

Authors:  Shannon R Morey; Dominic J Smiraglia; Smitha R James; Jihnhee Yu; Michael T Moser; Barbara A Foster; Adam R Karpf
Journal:  Cancer Res       Date:  2006-12-15       Impact factor: 12.701

5.  5-aza-2'-deoxycytidine delays androgen-independent disease and improves survival in the transgenic adenocarcinoma of the mouse prostate mouse model of prostate cancer.

Authors:  Christoph S Zorn; Kirk J Wojno; Michael T McCabe; Rainer Kuefer; Juergen E Gschwend; Mark L Day
Journal:  Clin Cancer Res       Date:  2007-04-01       Impact factor: 12.531

6.  Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.

Authors:  N-Y Cho; B-H Kim; M Choi; E J Yoo; K C Moon; Y-M Cho; D Kim; G H Kang
Journal:  J Pathol       Date:  2007-02       Impact factor: 7.996

7.  Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.

Authors:  Rui Henrique; Carmen Jerónimo; Manuel R Teixeira; Mohammad O Hoque; André L Carvalho; Irene Pais; Franclim R Ribeiro; Jorge Oliveira; Carlos Lopes; David Sidransky
Journal:  Mol Cancer Res       Date:  2006-01       Impact factor: 5.852

8.  Predicting aberrant CpG island methylation.

Authors:  F A Feltus; E K Lee; J F Costello; C Plass; P M Vertino
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

9.  DNA motifs associated with aberrant CpG island methylation.

Authors:  F Alex Feltus; Eva K Lee; Joseph F Costello; Christoph Plass; Paula M Vertino
Journal:  Genomics       Date:  2006-02-17       Impact factor: 5.736

10.  Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model.

Authors:  Paula J Kaplan-Lefko; Tsuey-Ming Chen; Michael M Ittmann; Roberto J Barrios; Gustavo E Ayala; Wendy J Huss; Lisette A Maddison; Barbara A Foster; Norman M Greenberg
Journal:  Prostate       Date:  2003-05-15       Impact factor: 4.104

View more
  34 in total

Review 1.  Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition.

Authors:  Stephanie M Tortorella; Simon G Royce; Paul V Licciardi; Tom C Karagiannis
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

2.  p16 hypermethylation: a biomarker for increased esophageal cancer susceptibility in high incidence region of North East India.

Authors:  Mandakini Das; Bhaskar Jyoti Saikia; Santanu Kumar Sharma; Gaganpreet Singh Sekhon; Jagadish Mahanta; Rup Kumar Phukan
Journal:  Tumour Biol       Date:  2014-11-01

3.  Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis.

Authors:  Susanne M Henning; Piwen Wang; Jonathan Said; Clara Magyar; Brandon Castor; Ngan Doan; Carmen Tosity; Aune Moro; Kun Gao; Luyi Li; David Heber
Journal:  J Nutr Biochem       Date:  2012-03-08       Impact factor: 6.048

4.  Hypermethylation of a cluster of Krüppel-type zinc finger protein genes on chromosome 19q13 in oropharyngeal squamous cell carcinoma.

Authors:  Roberto A Lleras; Leslie R Adrien; Richard V Smith; Benjamin Brown; Naheed Jivraj; Christopher Keller; Cathy Sarta; Nicolas F Schlecht; Thomas M Harris; Geoffrey Childs; Michael B Prystowsky; Thomas J Belbin
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

5.  Dietary folate deficiency blocks prostate cancer progression in the TRAMP model.

Authors:  Gaia Bistulfi; Barbara A Foster; Ellen Karasik; Bryan Gillard; Jeff Miecznikowski; Vineet K Dhiman; Dominic J Smiraglia
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-11

6.  Folate deficiency exacerbates apoptosis by inducing hypomethylation and resultant overexpression of DR4 together with altering DNMTs in Alzheimer's disease.

Authors:  Yun Wang; Shunliang Xu; Yanjun Cao; Zhaohong Xie; Chao Lai; Xiaowei Ji; Jianzhong Bi
Journal:  Int J Clin Exp Med       Date:  2014-08-15

7.  Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors.

Authors:  Cory K Mavis; Shannon R Morey Kinney; Barbara A Foster; Adam R Karpf
Journal:  Prostate       Date:  2009-09-01       Impact factor: 4.104

8.  Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate.

Authors:  Shannon R Morey Kinney; Wa Zhang; Marien Pascual; John M Greally; Bryan M Gillard; Ellen Karasik; Barbara A Foster; Adam R Karpf
Journal:  Cancer Prev Res (Phila)       Date:  2009-11-24

9.  Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice.

Authors:  Siwang Yu; Tin Oo Khor; Ka-Lung Cheung; Wenge Li; Tien-Yuan Wu; Ying Huang; Barbara A Foster; Yuet Wai Kan; Ah-Ng Kong
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

10.  DNA methylation-mediated down-regulation of DNA methyltransferase-1 (DNMT1) is coincident with, but not essential for, global hypomethylation in human placenta.

Authors:  Boris Novakovic; Nick C Wong; Mandy Sibson; Hong-Kiat Ng; Ruth Morley; Ursula Manuelpillai; Thomas Down; Vardhman K Rakyan; Stephan Beck; Stefan Hiendleder; Claire T Roberts; Jeffrey M Craig; Richard Saffery
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.